Not bad, eh. Happily holding.
--QUOTE--
VANCOUVER , Nov. 13, 2015 /CNW/ - Endeavour Mining Corporation ("Endeavour Mining") (EDV.TO) (EVR.AX) (EDVMF) announces Q3 2015 gold production of 124,893 ounces resulting in an all-in sustaining margin of $26.1 million . Over the nine month period to September 30, 2015 , Endeavour Mining has produced 379,802 ounces at an AISC/oz of $917 resulting in an all-in sustaining margin of $98.2 million . Endeavour Mining's operations continue to perform well and are positioned to deliver at the high end of production guidance of 475,000 to 500,000 ounces with AISC/oz below our full-year $930 to $980 /oz guidance range.
(All amounts in US dollars unless otherwise indicated)
Q3 2015 Financial and Operating Highlights
- Gold production of 124,893 ounces and sales of 123,002 ounces at a realized gold price of $1,121 per ounce
- Cash cost per ounce sold of $710
- Operating EBITDA of $36.3 million
- AISC per ounce sold of $908
- AISC margin of $26.1 million
- Non-sustaining capital and exploration investments of $13 million
- A $20 million advance principal payment was made in July 2015 to further reduce the drawn amount on the revolving credit facility to $260 million . Advance principal payments have totaled $40 million so far this year.
- Ended Q3 2015 with $31.8 million in cash
- The third quarter results do not include the contributions from Ity Gold Mine in Côte d'Ivoire, acquired via the La Mancha transaction subsequent to quarter end in November 2015 . At closing, Endeavour Mining will benefit from the cash flow generated from the Ity mine and will strengthen its balance sheet and funding position from the $63 million attributable cash amount to be received from the La Mancha transaction
- Forums
- ASX - By Stock
- EVR
- High end of guidance
EVR
ev resources ltd
Add to My Watchlist
0.00%
!
0.9¢

High end of guidance
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
0.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $17.87M |
Open | High | Low | Value | Volume |
0.8¢ | 0.9¢ | 0.8¢ | $34.82K | 4.152M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
9 | 9345335 | 0.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.9¢ | 2471309 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
9 | 9345335 | 0.007 |
7 | 15966665 | 0.006 |
7 | 4287033 | 0.005 |
16 | 3249221 | 0.004 |
18 | 29346084 | 0.003 |
Price($) | Vol. | No. |
---|---|---|
0.009 | 2471309 | 5 |
0.010 | 2084073 | 5 |
0.011 | 1530133 | 6 |
0.012 | 550000 | 3 |
0.013 | 2188993 | 1 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
EVR (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online